Two studies led by a researcher at UT Southwestern Medical Center show the effects of different SARS-CoV-2 variants on lung tissue, revealing what may cause some COVID-19 infections to be more severe than others. Both studies, ...
Jan 15, 2024
0
86
Understanding how viruses travel once inside the human body is critical to develop effective drugs and therapies that can stop viruses in their tracks. Scientists at Texas Biomedical Research Institute (Texas Biomed) recently ...
Dec 18, 2023
0
53
Newspaper headlines from the U.S. to the U.K. and most places in between highlight the surge in sick patients suffering from respiratory viruses. The so-called "tripledemic" of lung infections including respiratory synclinal ...
At the beginning of the COVID pandemic, we were hopeful that pre-existing immunity to the common cold could protect you from COVID, but new evidence suggests that sometimes the opposite can happen. A new University of Rochester ...
Mar 7, 2022
0
147
The human papillomavirus (HPV) can cause cancer and many countries run national vaccination programs to minimize the risk. Studies involving researchers at German Cancer Research Center, Karolinska Institutet and Tampere ...
May 31, 2021
0
17
A year ago scientists everywhere were scrambling to get their minds around the SARS-CoV-2, a novel coronavirus that caused the pandemic from which we are only now beginning to emerge. The world clung to every new development, ...
Mar 31, 2021
0
94
The common cold virus could offer some level of protection against COVID-19 infection, according to a new study.
Mar 23, 2021
0
229
A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed against the coronavirus that causes Middle East respiratory syndrome (MERS) found that they were well tolerated and generally ...
Feb 23, 2021
0
29
Of the seven coronaviruses known to infect people, four cause common respiratory infections that are sharply seasonal and appear to transmit similarly to influenza, according to a new study by University of Michigan School ...
Apr 8, 2020
0
374
Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results, published ...
Nov 13, 2018
0
58
